1900 Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$331K Buy
5,736
+1,291
+29% +$74.1K 0.02% 237
2026
Q1
$270K Buy
+4,445
New +$259K 0.02% 226
2022
Q1
– Sell
-3,973
Closed -$248K – 240
2021
Q4
$248K Sell
3,973
-15
-0.4% -$880 0.02% 214
2021
Q3
$236K Hold
3,988
– – 0.02% 199
2021
Q2
$267K Buy
3,988
+120
+3% +$7.83K 0.03% 191
2021
Q1
$244K Buy
+3,868
New +$241K 0.02% 155

Other funds holding BMY

1900 Wealth Management's BMY Position: Q2 2026 in Review

1900 Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, buying an estimated $74.1K and bringing the position to 5,736 shares worth $331K. The position accounts for 0.02% of the portfolio, ranked #237.

1900 Wealth Management first reported a position in BMY in Q1 2021 and has held it in 6 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • 1900 Wealth Management held 5,736 shares of Bristol-Myers Squibb worth $331K as of Q2 2026.
  • 1900 Wealth Management bought 1,291 Bristol-Myers Squibb shares in Q2 2026, an estimated $74.1K.
  • Bristol-Myers Squibb made up 0.02% of 1900 Wealth Management's portfolio in Q2 2026, its #237 holding.
  • 1900 Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 6 quarters since.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on 1900 Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.